I definitely understand the desire to capture returns
in different parts of the market, but simplicity can often lead to better behavioral decisions without sacrificing much, if anything, in performance.
Consequently, the Commission's decision to «carve up»
the different parts of the market authorisation for a genetically modified organism into environmental aspects and non-environmental aspects is, according to the applicant, misplaced.
It is common for builders to try and cater to
different parts of the market.